These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15912851)

  • 1. ["High dosage monotherapy"].
    Schmieder RE
    Krankenpfl J; 2005; 43(1-3):63. PubMed ID: 15912851
    [No Abstract]   [Full Text] [Related]  

  • 2. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
    MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Olmesartan: antihypertensive therapy].
    Krankenpfl J; 2005; 43(7-10):254. PubMed ID: 16515323
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
    Vivencio B
    Curr Med Res Opin; 2009 Sep; 25(9):2267-8; author reply 2268-9. PubMed ID: 19630488
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fast to the blood pressure goal. Lengthy dose adjustments harm compliance].
    MMW Fortschr Med; 2003 Sep; 145(39):53. PubMed ID: 14649079
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modern hypertension treatment. More than effective blood pressure reduction].
    MMW Fortschr Med; 2012 Nov; 154(20):78-9. PubMed ID: 23234126
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
    Sarzani R; Dessì-Fulgheri P
    J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Valsartan: arguments for the high dose concept].
    MMW Fortschr Med; 2006 Dec; 148(51-52):54-5. PubMed ID: 17619348
    [No Abstract]   [Full Text] [Related]  

  • 10. [From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963998
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination treatment effective option for hypertensive, diabetic patients with microalbuminuria.
    Chen BH
    CMAJ; 2001 Mar; 164(6):861. PubMed ID: 11276560
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypertension: improved therapy adherence after switch to a fixed drug combinations].
    MMW Fortschr Med; 2012 Mar; 154(5):78-9. PubMed ID: 22624273
    [No Abstract]   [Full Text] [Related]  

  • 13. [New AT1 receptor antagonist. Rapid and effective blood pressure decrease].
    MMW Fortschr Med; 2003 Jan; 145(5):53. PubMed ID: 12619219
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension and diabetic nephropathy, a dangerous duo].
    Hausberg M; Hohage H; Kosch M
    Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of combination therapy in treatment of hypertension].
    Kreutz R
    Krankenpfl J; 2005; 43(7-10):255. PubMed ID: 16515324
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Olmesartan-associated Sprue-like Enteropathy.
    Nagashima K; Katsurada T; Sakamoto N
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):A45-A46. PubMed ID: 29247793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Milestone studies provide evidence: sartans have a nephroprotective effect. Evidence is clear].
    Bold KO
    MMW Fortschr Med; 2001 May; 143(22):12-3. PubMed ID: 11460392
    [No Abstract]   [Full Text] [Related]  

  • 19. [High dose sartan plus thiazide. Power duo in hypertension].
    MMW Fortschr Med; 2003 Feb; 145(6):60. PubMed ID: 12619369
    [No Abstract]   [Full Text] [Related]  

  • 20. [The future of hypertension management lies in the use of fixed combinations (interview by Dr. Silke Wedekind)].
    Linss G
    MMW Fortschr Med; 2012 Nov; 154(20):79. PubMed ID: 23234127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.